Literature DB >> 23066899

Generation of monoclonal antibody fragments binding the native γ-secretase complex for use in structural studies.

Jean-René Alattia1, Claude Schweizer, Matthias Cacquevel, Mitko Dimitrov, Lorène Aeschbach, Mustapha Oulad-Abdelghani, Patrick C Fraering.   

Abstract

A detailed understanding of γ-secretase structure is crucially needed to elucidate its unique properties of intramembrane protein cleavage and to design therapeutic compounds for the safe treatment of Alzheimer's disease. γ-Secretase is an enzyme complex composed of four membrane proteins, and the scarcity of its supply associated with the challenges of crystallizing membrane proteins is a major hurdle for the determination of its high-resolution structure. This study addresses some of these issues, first by adapting CHO cells overexpressing γ-secretase to growth in suspension, thus yielding multiliter cultures and milligram quantities of highly purified, active γ-secretase. Next, the amounts of γ-secretase were sufficient for immunization of mice and allowed generation of Nicastrin- and Aph-1-specific monoclonal antibodies, from which Fab fragments were proteolytically prepared and subsequently purified. The amounts of γ-secretase produced are compatible with robot-assisted crystallogenesis using nanoliter technologies. In addition, our Fab fragments bind exposed regions of native γ-secretase in a dose-dependent manner without interfering with its catalytic properties and can therefore be used as specific tools to facilitate crystal formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23066899     DOI: 10.1021/bi300997e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  1 in total

1.  Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.

Authors:  Aleksandra Filipović; Ylenia Lombardo; Monica Faronato; Monica Fronato; Joel Abrahams; Eric Aboagye; Quang-De Nguyen; Barbara Borda d'Aqua; Anne Ridley; Andrew Green; Emad Rahka; Ian Ellis; Chiara Recchi; Natasa Przulj; Anida Sarajlić; Jean-Rene Alattia; Patrick Fraering; Mahendra Deonarain; R Charles Coombes
Journal:  Breast Cancer Res Treat       Date:  2014-09-24       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.